The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFα

Journal of Physiology and Biochemistry

Volumn 61, Issue 2, 2005, Pages 395-401

  Garcia Vicente S ^b   Abella, A ^b   Viguerie, N ^a   Ros Baro A ^b   Camps, M ^b   Testar, X ^b   Palacin M ^b   Zorzano, A ^b   Marti, L ^b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

3T3 L1; Isoproterenol; Semicarbazide Sensitive Amine Oxidase; TNF ; Vascular Adhesion Protein 1

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ADHESION PROTEIN 1;

ADIPOCYTE; ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; METABOLITE; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; VASCULAR DISEASE;

ANIMALIA;

EID: 24644490168     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03167057     Document Type: Article

References (25)

1. Abella, A., Garcia-Vicente, S., Viguerie, N., Ros-Baro, A., Camps, M., Palacin, M., Zorzano, A. and Marti, L. (2004): Diabetologia, 47, 429-438.
2. Abella, A., Marti, L., Carpene, C., Palacin, M., Testar, X. and Zorzano, A. (2003): J. Physiol. Biochem., 59, 153-160.
3. Ahima, R. S. and Flier, J. S. (2000): Trends Endocrinol. Metab., 11, 327-332.
4. Blann, A. D., Tse, W., Maxwell, S. J. and Waite, M. A. (1994): J. Hypertens., 12, 925-928.
5. Bono, P., Jalkanen, S. and Salmi, M. (1999): Am. J. Pathol., 155, 1613-1624.
6. Boomsma, F., van den Meiracker, A. H., Winkel, S., Aanstoot, H. J., Batstra, M. R., Man in 't Veld, A. J. and Bruining, G. J. (1999): Diabetologia, 42, 233-237.
7. Boomsma, F., van Veldhuisen, D. J., de Kam, P. J., Man, i., Mosterd, A., Lie, K. I. and Schalekamp, M. A. (1997): Cardiovasc. Res., 33, 387-391.
8. Butcher, E. C. and Picker, L. J. (1996): Science, 272, 60-66.
9. Enrique-Tarancon, G., Marti, L., Morin, N., Lizcano, J. M., Unzeta, M., Sevilla, L., Camps, M., Palacin, M., Testar, X., Carpene, C. and Zorzano, A. (1998): J. Biol. Chem., 273, 8025-8032.
10. Fowler, C. J. and Tipton, K. F. (1981): Biochem. Pharmacol., 30, 3329-3332.
11. Gearing, A. J. and Newman, W. (1993): Immunol. Today, 14, 506-512.
12. Hackman, A., Abe, Y., Insull, W., Jr., Pownall, H., Smith, L., Dunn, K., Gotto, A. M., Jr. and Ballantyne, C. M. (1996): Circulation, 93, 1334-1338.
13. Hayes, B. E. and Clarke, D. E. (1990): Res. Commun. Chem. Pathol. Pharmacol., 69, 71-83.
14. Kurkijarvi, R., Adams, D. H., Leino, R., Mottonen, T., Jalkanen, S. and Salmi, M. (1998): J. Immunol., 161, 1549-1557.
15. Kurkijarvi, R., Jalkanen, S., Isoniemi, H. and Salmi, M. (2001): Eur. J. Immunol., 31, 2876-2884.
16. Lampeter, E. R., Kishimoto, T. K., Rothlein, R., Mainolfi, E. A., Bertrams, J., Kolb, H. and Martin, S. (1992): Diabetes, 41, 1668-1671.
17. Leinonen, E., Hurt-Camejo, E., Wiklund, O., Hulten, L. M., Hiukka, A. and Taskinen, M. R. (2003): Atherosclerosis, 166, 387-394.
18. Meszaros, Z., Szombathy, T., Raimondi, L., Karadi, I., Romics, L. and Magyar, K. (1999): Metabolism, 48, 113-117.
19. Moldes, M., Feve, B. and Pairault, J. (1999): J. Biol. Chem., 274, 9515-9523.
20. Morandini, R., Ghanem, G., Portier-Lemarie, A., Robaye, B., Renaud, A. and Boeynaems, J. M. (1996): Am. J. Physiol., 270, H807-H816.
21. Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J. and Allen, J. (1998): Lancet, 351, 88-92.
22. Ros-Baro, A., Lopez-Iglesias, C., Peiro, S., Bellido, D., Palacin, M., Zorzano, A. and Camps, M. (2001): Proc. Natl. Acad. Sci. USA, 98, 12050-12055.
23. Salmi, M. and Jalkanen, S. (1992): Science, 257, 1407-1409.
24. Salmi, M., Stolen, C., Jousilahti, P., Yegutkin, G. G., Tapanainen, P., Janatuinen, T., Knip, M., Jalkanen, S. and Salomaa, V. (2002): Am. J. Pathol., 161, 2255-2262.
25. Smith, D. J., Salmi, M., Bono, P., Hellman, J., Leu, T. and Jalkanen, S. (1998): J. Exp. Med., 188, 17-27.